Exagen to announce first quarter 2022 financial results on may 11, 2022

San diego, april 25, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended march 31, 2022, after the market close on wednesday, may 11, 2022. ron rocca, exagen's president and chief executive officer, kamal adawi, chief financial officer, and mark hazeltine, chief operating officer, will host a conference call to review the company's results at 4:30 pm et (1:30 pm pt).
XGN Ratings Summary
XGN Quant Ranking